category:news
Why the Tirzepatide shortage ending might be bad news.
Bad news that sounds like good news: FDA ends shortage Eli Lilly's GLP-1 (Tirzepatide). We'll tell you why that's bad news.
company:eli-lilly
company:eli-lilly
Eli Lilly's other new GLP1 - Orforglipron
Eli Lilly is developing new GLP1 drugs, and Orforglipron is one of them. It's not easy to pronounce, but it is easy to take, and easy to produce.
company:eli-lilly
Eli Lilly China approval and new suppliers
As the race to manufacture more GLP1 medications intensifies, Eli Lilly gets approval in China and more suppliers.